Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-100917
Filing Date
2025-07-31
Accepted
2025-07-31 16:15:51
Documents
63
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fblg-20250630.htm   iXBRL 10-Q 2303167
2 EX-10.1 fblg-ex10_1.htm EX-10.1 179694
3 EX-10.3 fblg-ex10_3.htm EX-10.3 135378
4 EX-31.1 fblg-ex31_1.htm EX-31.1 16118
5 EX-31.2 fblg-ex31_2.htm EX-31.2 16064
6 EX-32.1 fblg-ex32_1.htm EX-32.1 7451
  Complete submission text file 0000950170-25-100917.txt   8367128

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fblg-20250630.xsd EX-101.SCH 895264
66 EXTRACTED XBRL INSTANCE DOCUMENT fblg-20250630_htm.xml XML 1399388
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41934 | Film No.: 251171863
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)